BIOMAT Database Logo BIOMAT Database Logo

Potential folic acid antagonists. 4. Synthesis and dihydrofolate reductase inhibitory activities of 2,4,6-triamino-5-arylazopyrimidines. 1971

S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001391 Azo Compounds Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N Azo Dye,Azo Dyes,Compounds, Azo,Dye, Azo,Dyes, Azo
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Potential folic acid antagonists. 5. Synthesis and dihydrofolate reductase inhibitory activities of 2-amino-4,6-substituted-5-arylazopyrimidines.
December 1971, Journal of medicinal chemistry,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines.
November 1965, Journal of medicinal chemistry,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Potential folic acid antagonists. 3. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines.
May 1968, Journal of medicinal chemistry,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Potential folic acid antagonists. 6. Potential irreversible folate reductase inhibitors derived from 2,4-diamino-5-arylazopyrimidines.
December 1971, Journal of medicinal chemistry,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Synthesis and dihydrofolate reductase inhibitory activities of 2,4-diamino-5-deaza and 2,4-diamino-5,10-dideaza lipophilic antifolates.
February 1997, Journal of medicinal chemistry,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
[Dihydrofolate reductase and thymidine kinase in the bone marrow under the influence of folic acid antagonists].
October 1967, Klinische Wochenschrift,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Dihydrofolate reductase induced by folic acid in cultured human cells.
January 1973, Biochimica et biophysica acta,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Potential antineoplastics. IV. 2-amino-4-methyl-6-phenyl-5-arylazopyrimidines.
July 1970, Journal of medicinal chemistry,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
Investigation on inhibitory effect of folic acid on methotrexate-induced epithelial-mesenchymal transition focusing on dihydrofolate reductase.
December 2019, Drug metabolism and pharmacokinetics,
S S Chatterjee, and D R Garrison, and R Kaprove, and J F Moran, and A M Triggle, and D J Triggle, and A Wayne
SYNTHESIS AND ACTIVITY OF PHTHALYLGLUTAMIC ACID ANALOGS AS POTENTIAL FOLIC ACID ANTAGONISTS IN BACTERIA.
October 1964, Journal of pharmaceutical sciences,
Copied contents to your clipboard!